Neurology

The Skidki-na-vse® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
Largest Study on MS Discovers Critical Genetic Component to Disease
Study offers a new perspective on the molecular events that may lead some individuals to develop multiple sclerosis.
NIH-Funded Research Centers Launched with Focus on Alzheimer Drug Development
The National Institute on Aging (NIA) has launched 2 new research centers, the Alzheimer Centers for the Discovery of New Medicines, designed to diversify and strengthen the Alzheimer disease drug development pipeline.
Ofatumumab Demonstrates Efficacy in Relapsing Multiple Sclerosis
Two phase 3 studies showed that ofatumumab was superior to teriflunomide (Aubagio) in patients with relapsing forms of multiple sclerosis.
 
American Academy of Neurology Guidelines on Immunizations in Multiple Sclerosis
New updates to immunization guidelines in multiple sclerosis outline recommendations on vaccination decisions for patients.
Raising Levels of High-Density Lipoprotein May Reduce MS-Related Fatigue
Dietary interventions that raise levels of high-density lipoprotein, or good cholesterol, may affect fatigue symptoms in multiple sclerosis.
Out-of-Pocket Costs Grew 7-Fold for Medicare Beneficiaries with Multiple Sclerosis
Rising drug prices for disease-modifying therapies resulted in substantial increases in spending for Medicare beneficiaries with multiple sclerosis.
FDA Approves Istradefylline Tablets for Treating Off-Episodes in Parkinson Disease
Istradefylline tablets (Nourianz, Kyowa Kirin) are indicated to assist patients who are experiencing 'off' episodes, better defined as a time when a patient’s medications are not working well.
Vegetable-Based Diet Leads to Lower Fatigue in Patients with Multiple Sclerosis
Patients with progressive multiple sclerosis who were placed on the Wahls diet, which is high in fruits and vegetables, found to experience improved fatigue levels.
New Congress Offers Expert Evaluation of Latest Neurology Trends
The 1st annual International Congress on the Future of Neurology will be held on September 27-28, 2019 in New York City, featuring a rigourous agenda of presentations, question and answer sessions, and lightning rounds highlighting topics across the breadth of neurology. 
Future of Neurology Congress to Highlight New Data, Best Practices
The 1st annual International Congress on the Future of Neurology will be held on September 27-28, 2019 in New York City, featuring a rigorous agenda of presentations, question and answer sessions, and lightning rounds highlighting topics across the breadth of neurology.
New Collaboration Targets Demyelinating Diseases
Rewind Therapeutics, a private Belgian biotech company developing remyelinating therapies for myelin-affecting diseases, has been awarded a €2.9 million grant from Flanders Innovation and Entrepreneurship (VLAIO) for a new industry-academic research and development collaboration.
+ Load More